nodes	percent_of_prediction	percent_of_DWPC	metapath
Ceftizoxime—SLC15A1—Proton/oligonucleotide cotransporters—SLC15A2—multiple sclerosis	0.107	0.737	CbGpPWpGaD
Ceftizoxime—Nephropathy toxic—Mitoxantrone—multiple sclerosis	0.0203	0.0275	CcSEcCtD
Ceftizoxime—Cellulitis—Cladribine—multiple sclerosis	0.0195	0.0265	CcSEcCtD
Ceftizoxime—Ceftibuten—SLC15A2—multiple sclerosis	0.0171	0.144	CrCbGaD
Ceftizoxime—Aplastic anaemia—Cladribine—multiple sclerosis	0.0166	0.0226	CcSEcCtD
Ceftizoxime—Phlebitis—Cladribine—multiple sclerosis	0.0149	0.0203	CcSEcCtD
Ceftizoxime—SLC15A1—Amino acid and oligopeptide SLC transporters—SLC15A2—multiple sclerosis	0.0145	0.0993	CbGpPWpGaD
Ceftizoxime—Haemolytic anaemia—Cladribine—multiple sclerosis	0.0142	0.0193	CcSEcCtD
Ceftizoxime—Cefepime—SLC15A2—multiple sclerosis	0.0141	0.119	CrCbGaD
Ceftizoxime—Aplastic anaemia—Azathioprine—multiple sclerosis	0.0135	0.0184	CcSEcCtD
Ceftizoxime—Cefuroxime—SLC15A2—multiple sclerosis	0.0127	0.107	CrCbGaD
Ceftizoxime—Leukopenia—Fingolimod—multiple sclerosis	0.0122	0.0166	CcSEcCtD
Ceftizoxime—Toxic epidermal necrolysis—Cladribine—multiple sclerosis	0.0116	0.0157	CcSEcCtD
Ceftizoxime—Eosinophilia—Cladribine—multiple sclerosis	0.011	0.0149	CcSEcCtD
Ceftizoxime—Cefixime—SLC15A2—multiple sclerosis	0.011	0.0929	CrCbGaD
Ceftizoxime—Pancytopenia—Cladribine—multiple sclerosis	0.0105	0.0143	CcSEcCtD
Ceftizoxime—Neutropenia—Cladribine—multiple sclerosis	0.0104	0.0141	CcSEcCtD
Ceftizoxime—Ceftazidime—SLC15A2—multiple sclerosis	0.0103	0.0873	CrCbGaD
Ceftizoxime—Cefdinir—SLC15A2—multiple sclerosis	0.0101	0.0857	CrCbGaD
Ceftizoxime—Paraesthesia—Fingolimod—multiple sclerosis	0.01	0.0136	CcSEcCtD
Ceftizoxime—Stevens-Johnson syndrome—Cladribine—multiple sclerosis	0.00982	0.0133	CcSEcCtD
Ceftizoxime—Phlebitis—Mitoxantrone—multiple sclerosis	0.0098	0.0133	CcSEcCtD
Ceftizoxime—Cefradine—SLC15A2—multiple sclerosis	0.00964	0.0815	CrCbGaD
Ceftizoxime—Toxic epidermal necrolysis—Azathioprine—multiple sclerosis	0.00941	0.0128	CcSEcCtD
Ceftizoxime—Haemoglobin—Cladribine—multiple sclerosis	0.00894	0.0121	CcSEcCtD
Ceftizoxime—Haemorrhage—Cladribine—multiple sclerosis	0.00889	0.0121	CcSEcCtD
Ceftizoxime—Pancytopenia—Azathioprine—multiple sclerosis	0.00858	0.0117	CcSEcCtD
Ceftizoxime—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC15A2—multiple sclerosis	0.00852	0.0585	CbGpPWpGaD
Ceftizoxime—Erythema multiforme—Cladribine—multiple sclerosis	0.00841	0.0114	CcSEcCtD
Ceftizoxime—Stevens-Johnson syndrome—Azathioprine—multiple sclerosis	0.00798	0.0108	CcSEcCtD
Ceftizoxime—Cefotaxime—SLC15A2—multiple sclerosis	0.00795	0.0672	CrCbGaD
Ceftizoxime—Pruritus—Fingolimod—multiple sclerosis	0.00788	0.0107	CcSEcCtD
Ceftizoxime—Ceftriaxone—SLC15A2—multiple sclerosis	0.00784	0.0662	CrCbGaD
Ceftizoxime—Diarrhoea—Fingolimod—multiple sclerosis	0.00762	0.0104	CcSEcCtD
Ceftizoxime—Agranulocytosis—Azathioprine—multiple sclerosis	0.00751	0.0102	CcSEcCtD
Ceftizoxime—Haemoglobin—Azathioprine—multiple sclerosis	0.00727	0.00987	CcSEcCtD
Ceftizoxime—Haemorrhage—Azathioprine—multiple sclerosis	0.00723	0.00982	CcSEcCtD
Ceftizoxime—Anaemia—Cladribine—multiple sclerosis	0.00715	0.00972	CcSEcCtD
Ceftizoxime—Pancytopenia—Mitoxantrone—multiple sclerosis	0.00693	0.00942	CcSEcCtD
Ceftizoxime—Cefalotin—SLC15A2—multiple sclerosis	0.00686	0.058	CrCbGaD
Ceftizoxime—Erythema multiforme—Azathioprine—multiple sclerosis	0.00683	0.00929	CcSEcCtD
Ceftizoxime—Neutropenia—Mitoxantrone—multiple sclerosis	0.00683	0.00928	CcSEcCtD
Ceftizoxime—Cephalexin—SLC15A2—multiple sclerosis	0.00624	0.0527	CrCbGaD
Ceftizoxime—Thrombocytopenia—Cladribine—multiple sclerosis	0.00618	0.0084	CcSEcCtD
Ceftizoxime—Agranulocytosis—Mitoxantrone—multiple sclerosis	0.00607	0.00826	CcSEcCtD
Ceftizoxime—Haemoglobin—Mitoxantrone—multiple sclerosis	0.00587	0.00798	CcSEcCtD
Ceftizoxime—Haemorrhage—Mitoxantrone—multiple sclerosis	0.00584	0.00794	CcSEcCtD
Ceftizoxime—Anaemia—Azathioprine—multiple sclerosis	0.00582	0.0079	CcSEcCtD
Ceftizoxime—Vaginal inflammation—Methotrexate—multiple sclerosis	0.0058	0.00788	CcSEcCtD
Ceftizoxime—Paraesthesia—Cladribine—multiple sclerosis	0.00567	0.00771	CcSEcCtD
Ceftizoxime—Leukopenia—Azathioprine—multiple sclerosis	0.00563	0.00765	CcSEcCtD
Ceftizoxime—Vaginal infection—Methotrexate—multiple sclerosis	0.00547	0.00744	CcSEcCtD
Ceftizoxime—Aplastic anaemia—Methotrexate—multiple sclerosis	0.00544	0.0074	CcSEcCtD
Ceftizoxime—Pain—Cladribine—multiple sclerosis	0.0054	0.00734	CcSEcCtD
Ceftizoxime—Thrombocytopenia—Azathioprine—multiple sclerosis	0.00503	0.00683	CcSEcCtD
Ceftizoxime—Body temperature increased—Cladribine—multiple sclerosis	0.00499	0.00679	CcSEcCtD
Ceftizoxime—Haemoglobin—Prednisolone—multiple sclerosis	0.00482	0.00655	CcSEcCtD
Ceftizoxime—Haemorrhage—Prednisolone—multiple sclerosis	0.00479	0.00652	CcSEcCtD
Ceftizoxime—Anaemia—Mitoxantrone—multiple sclerosis	0.0047	0.00639	CcSEcCtD
Ceftizoxime—Hypersensitivity—Cladribine—multiple sclerosis	0.00465	0.00632	CcSEcCtD
Ceftizoxime—Leukopenia—Mitoxantrone—multiple sclerosis	0.00455	0.00619	CcSEcCtD
Ceftizoxime—Pruritus—Cladribine—multiple sclerosis	0.00447	0.00607	CcSEcCtD
Ceftizoxime—Haemoglobin—Triamcinolone—multiple sclerosis	0.00443	0.00602	CcSEcCtD
Ceftizoxime—Haemoglobin—Methylprednisolone—multiple sclerosis	0.00442	0.00601	CcSEcCtD
Ceftizoxime—Haemorrhage—Triamcinolone—multiple sclerosis	0.00441	0.00599	CcSEcCtD
Ceftizoxime—Convulsion—Mitoxantrone—multiple sclerosis	0.00441	0.00599	CcSEcCtD
Ceftizoxime—Haemorrhage—Methylprednisolone—multiple sclerosis	0.0044	0.00598	CcSEcCtD
Ceftizoxime—Diarrhoea—Cladribine—multiple sclerosis	0.00432	0.00587	CcSEcCtD
Ceftizoxime—Anaphylactic shock—Mitoxantrone—multiple sclerosis	0.00415	0.00564	CcSEcCtD
Ceftizoxime—Neutropenia—Prednisone—multiple sclerosis	0.00407	0.00553	CcSEcCtD
Ceftizoxime—Thrombocytopenia—Mitoxantrone—multiple sclerosis	0.00406	0.00552	CcSEcCtD
Ceftizoxime—Body temperature increased—Azathioprine—multiple sclerosis	0.00406	0.00552	CcSEcCtD
Ceftizoxime—Haemoglobin—Dexamethasone—multiple sclerosis	0.00402	0.00546	CcSEcCtD
Ceftizoxime—Haemoglobin—Betamethasone—multiple sclerosis	0.00402	0.00546	CcSEcCtD
Ceftizoxime—Vomiting—Cladribine—multiple sclerosis	0.00402	0.00546	CcSEcCtD
Ceftizoxime—Haemorrhage—Dexamethasone—multiple sclerosis	0.004	0.00544	CcSEcCtD
Ceftizoxime—Haemorrhage—Betamethasone—multiple sclerosis	0.004	0.00544	CcSEcCtD
Ceftizoxime—Rash—Cladribine—multiple sclerosis	0.00398	0.00541	CcSEcCtD
Ceftizoxime—Dermatitis—Cladribine—multiple sclerosis	0.00398	0.00541	CcSEcCtD
Ceftizoxime—SLC15A1—SLC-mediated transmembrane transport—SLC15A2—multiple sclerosis	0.00381	0.0261	CbGpPWpGaD
Ceftizoxime—Toxic epidermal necrolysis—Methotrexate—multiple sclerosis	0.00379	0.00515	CcSEcCtD
Ceftizoxime—Hypersensitivity—Azathioprine—multiple sclerosis	0.00378	0.00514	CcSEcCtD
Ceftizoxime—Nausea—Cladribine—multiple sclerosis	0.00375	0.0051	CcSEcCtD
Ceftizoxime—Paraesthesia—Mitoxantrone—multiple sclerosis	0.00373	0.00507	CcSEcCtD
Ceftizoxime—Convulsion—Prednisolone—multiple sclerosis	0.00362	0.00491	CcSEcCtD
Ceftizoxime—Eosinophilia—Methotrexate—multiple sclerosis	0.0036	0.00489	CcSEcCtD
Ceftizoxime—Pain—Mitoxantrone—multiple sclerosis	0.00355	0.00482	CcSEcCtD
Ceftizoxime—Diarrhoea—Azathioprine—multiple sclerosis	0.00351	0.00478	CcSEcCtD
Ceftizoxime—Haemoglobin—Prednisone—multiple sclerosis	0.0035	0.00476	CcSEcCtD
Ceftizoxime—Haemorrhage—Prednisone—multiple sclerosis	0.00348	0.00473	CcSEcCtD
Ceftizoxime—Pancytopenia—Methotrexate—multiple sclerosis	0.00345	0.00469	CcSEcCtD
Ceftizoxime—Anaphylactic shock—Prednisolone—multiple sclerosis	0.00341	0.00463	CcSEcCtD
Ceftizoxime—Neutropenia—Methotrexate—multiple sclerosis	0.0034	0.00462	CcSEcCtD
Ceftizoxime—Convulsion—Triamcinolone—multiple sclerosis	0.00333	0.00452	CcSEcCtD
Ceftizoxime—Convulsion—Methylprednisolone—multiple sclerosis	0.00332	0.00451	CcSEcCtD
Ceftizoxime—Body temperature increased—Mitoxantrone—multiple sclerosis	0.00328	0.00446	CcSEcCtD
Ceftizoxime—Vomiting—Azathioprine—multiple sclerosis	0.00327	0.00444	CcSEcCtD
Ceftizoxime—Rash—Azathioprine—multiple sclerosis	0.00324	0.0044	CcSEcCtD
Ceftizoxime—Dermatitis—Azathioprine—multiple sclerosis	0.00324	0.0044	CcSEcCtD
Ceftizoxime—Stevens-Johnson syndrome—Methotrexate—multiple sclerosis	0.00322	0.00437	CcSEcCtD
Ceftizoxime—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.00313	0.00426	CcSEcCtD
Ceftizoxime—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.00313	0.00425	CcSEcCtD
Ceftizoxime—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.00306	0.00416	CcSEcCtD
Ceftizoxime—Paraesthesia—Prednisolone—multiple sclerosis	0.00306	0.00416	CcSEcCtD
Ceftizoxime—Nausea—Azathioprine—multiple sclerosis	0.00305	0.00415	CcSEcCtD
Ceftizoxime—Agranulocytosis—Methotrexate—multiple sclerosis	0.00303	0.00411	CcSEcCtD
Ceftizoxime—Convulsion—Dexamethasone—multiple sclerosis	0.00302	0.0041	CcSEcCtD
Ceftizoxime—Convulsion—Betamethasone—multiple sclerosis	0.00302	0.0041	CcSEcCtD
Ceftizoxime—Haemoglobin—Methotrexate—multiple sclerosis	0.00293	0.00398	CcSEcCtD
Ceftizoxime—Pain—Prednisolone—multiple sclerosis	0.00291	0.00396	CcSEcCtD
Ceftizoxime—Haemorrhage—Methotrexate—multiple sclerosis	0.00291	0.00396	CcSEcCtD
Ceftizoxime—SLC15A1—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	0.00289	0.0198	CbGpPWpGaD
Ceftizoxime—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.00284	0.00386	CcSEcCtD
Ceftizoxime—Anaphylactic shock—Betamethasone—multiple sclerosis	0.00284	0.00386	CcSEcCtD
Ceftizoxime—Diarrhoea—Mitoxantrone—multiple sclerosis	0.00284	0.00386	CcSEcCtD
Ceftizoxime—Paraesthesia—Triamcinolone—multiple sclerosis	0.00281	0.00382	CcSEcCtD
Ceftizoxime—Paraesthesia—Methylprednisolone—multiple sclerosis	0.00281	0.00381	CcSEcCtD
Ceftizoxime—Anaemia—Prednisone—multiple sclerosis	0.0028	0.00381	CcSEcCtD
Ceftizoxime—Thrombocytopenia—Betamethasone—multiple sclerosis	0.00278	0.00378	CcSEcCtD
Ceftizoxime—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.00278	0.00378	CcSEcCtD
Ceftizoxime—Erythema multiforme—Methotrexate—multiple sclerosis	0.00275	0.00374	CcSEcCtD
Ceftizoxime—Pain—Triamcinolone—multiple sclerosis	0.00268	0.00364	CcSEcCtD
Ceftizoxime—Vomiting—Mitoxantrone—multiple sclerosis	0.00264	0.00359	CcSEcCtD
Ceftizoxime—Convulsion—Prednisone—multiple sclerosis	0.00263	0.00357	CcSEcCtD
Ceftizoxime—Rash—Mitoxantrone—multiple sclerosis	0.00262	0.00356	CcSEcCtD
Ceftizoxime—Dermatitis—Mitoxantrone—multiple sclerosis	0.00262	0.00355	CcSEcCtD
Ceftizoxime—Paraesthesia—Betamethasone—multiple sclerosis	0.00255	0.00347	CcSEcCtD
Ceftizoxime—Paraesthesia—Dexamethasone—multiple sclerosis	0.00255	0.00347	CcSEcCtD
Ceftizoxime—Hypersensitivity—Prednisolone—multiple sclerosis	0.00251	0.00341	CcSEcCtD
Ceftizoxime—Body temperature increased—Triamcinolone—multiple sclerosis	0.00248	0.00336	CcSEcCtD
Ceftizoxime—Anaphylactic shock—Prednisone—multiple sclerosis	0.00248	0.00336	CcSEcCtD
Ceftizoxime—Nausea—Mitoxantrone—multiple sclerosis	0.00247	0.00335	CcSEcCtD
Ceftizoxime—Pain—Betamethasone—multiple sclerosis	0.00243	0.0033	CcSEcCtD
Ceftizoxime—Pain—Dexamethasone—multiple sclerosis	0.00243	0.0033	CcSEcCtD
Ceftizoxime—Anaemia—Methotrexate—multiple sclerosis	0.00234	0.00318	CcSEcCtD
Ceftizoxime—Hypersensitivity—Triamcinolone—multiple sclerosis	0.00231	0.00314	CcSEcCtD
Ceftizoxime—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.0023	0.00313	CcSEcCtD
Ceftizoxime—Leukopenia—Methotrexate—multiple sclerosis	0.00227	0.00308	CcSEcCtD
Ceftizoxime—Body temperature increased—Betamethasone—multiple sclerosis	0.00225	0.00305	CcSEcCtD
Ceftizoxime—Body temperature increased—Dexamethasone—multiple sclerosis	0.00225	0.00305	CcSEcCtD
Ceftizoxime—Paraesthesia—Prednisone—multiple sclerosis	0.00222	0.00302	CcSEcCtD
Ceftizoxime—Pruritus—Triamcinolone—multiple sclerosis	0.00222	0.00301	CcSEcCtD
Ceftizoxime—Pruritus—Methylprednisolone—multiple sclerosis	0.00221	0.003	CcSEcCtD
Ceftizoxime—Convulsion—Methotrexate—multiple sclerosis	0.0022	0.00298	CcSEcCtD
Ceftizoxime—Rash—Prednisolone—multiple sclerosis	0.00215	0.00292	CcSEcCtD
Ceftizoxime—Dermatitis—Prednisolone—multiple sclerosis	0.00215	0.00292	CcSEcCtD
Ceftizoxime—Diarrhoea—Methylprednisolone—multiple sclerosis	0.00214	0.00291	CcSEcCtD
Ceftizoxime—Anaphylactic shock—Methotrexate—multiple sclerosis	0.00207	0.00281	CcSEcCtD
Ceftizoxime—Thrombocytopenia—Methotrexate—multiple sclerosis	0.00203	0.00275	CcSEcCtD
Ceftizoxime—Nausea—Prednisolone—multiple sclerosis	0.00202	0.00275	CcSEcCtD
Ceftizoxime—SLC15A1—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	0.00202	0.0138	CbGpPWpGaD
Ceftizoxime—Pruritus—Betamethasone—multiple sclerosis	0.00201	0.00273	CcSEcCtD
Ceftizoxime—Pruritus—Dexamethasone—multiple sclerosis	0.00201	0.00273	CcSEcCtD
Ceftizoxime—Vomiting—Triamcinolone—multiple sclerosis	0.00199	0.00271	CcSEcCtD
Ceftizoxime—Vomiting—Methylprednisolone—multiple sclerosis	0.00199	0.0027	CcSEcCtD
Ceftizoxime—Rash—Triamcinolone—multiple sclerosis	0.00197	0.00268	CcSEcCtD
Ceftizoxime—Dermatitis—Triamcinolone—multiple sclerosis	0.00197	0.00268	CcSEcCtD
Ceftizoxime—Rash—Methylprednisolone—multiple sclerosis	0.00197	0.00268	CcSEcCtD
Ceftizoxime—Dermatitis—Methylprednisolone—multiple sclerosis	0.00197	0.00268	CcSEcCtD
Ceftizoxime—Body temperature increased—Prednisone—multiple sclerosis	0.00196	0.00266	CcSEcCtD
Ceftizoxime—Diarrhoea—Betamethasone—multiple sclerosis	0.00194	0.00264	CcSEcCtD
Ceftizoxime—Diarrhoea—Dexamethasone—multiple sclerosis	0.00194	0.00264	CcSEcCtD
Ceftizoxime—SLC15A1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.00194	0.0133	CbGpPWpGaD
Ceftizoxime—Nausea—Triamcinolone—multiple sclerosis	0.00186	0.00253	CcSEcCtD
Ceftizoxime—Paraesthesia—Methotrexate—multiple sclerosis	0.00186	0.00252	CcSEcCtD
Ceftizoxime—Nausea—Methylprednisolone—multiple sclerosis	0.00186	0.00252	CcSEcCtD
Ceftizoxime—Hypersensitivity—Prednisone—multiple sclerosis	0.00182	0.00248	CcSEcCtD
Ceftizoxime—Vomiting—Dexamethasone—multiple sclerosis	0.00181	0.00246	CcSEcCtD
Ceftizoxime—Vomiting—Betamethasone—multiple sclerosis	0.00181	0.00246	CcSEcCtD
Ceftizoxime—Rash—Betamethasone—multiple sclerosis	0.00179	0.00244	CcSEcCtD
Ceftizoxime—Rash—Dexamethasone—multiple sclerosis	0.00179	0.00244	CcSEcCtD
Ceftizoxime—Dermatitis—Dexamethasone—multiple sclerosis	0.00179	0.00243	CcSEcCtD
Ceftizoxime—Dermatitis—Betamethasone—multiple sclerosis	0.00179	0.00243	CcSEcCtD
Ceftizoxime—Pain—Methotrexate—multiple sclerosis	0.00177	0.0024	CcSEcCtD
Ceftizoxime—Pruritus—Prednisone—multiple sclerosis	0.00175	0.00238	CcSEcCtD
Ceftizoxime—Diarrhoea—Prednisone—multiple sclerosis	0.00169	0.0023	CcSEcCtD
Ceftizoxime—Nausea—Dexamethasone—multiple sclerosis	0.00169	0.00229	CcSEcCtD
Ceftizoxime—Nausea—Betamethasone—multiple sclerosis	0.00169	0.00229	CcSEcCtD
Ceftizoxime—Ceftriaxone—ALB—multiple sclerosis	0.00169	0.0142	CrCbGaD
Ceftizoxime—Body temperature increased—Methotrexate—multiple sclerosis	0.00164	0.00222	CcSEcCtD
Ceftizoxime—Vomiting—Prednisone—multiple sclerosis	0.00157	0.00214	CcSEcCtD
Ceftizoxime—Rash—Prednisone—multiple sclerosis	0.00156	0.00212	CcSEcCtD
Ceftizoxime—Dermatitis—Prednisone—multiple sclerosis	0.00156	0.00212	CcSEcCtD
Ceftizoxime—Hypersensitivity—Methotrexate—multiple sclerosis	0.00152	0.00207	CcSEcCtD
Ceftizoxime—Cefalotin—ALB—multiple sclerosis	0.00148	0.0125	CrCbGaD
Ceftizoxime—Nausea—Prednisone—multiple sclerosis	0.00147	0.002	CcSEcCtD
Ceftizoxime—SLC15A1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.00147	0.0101	CbGpPWpGaD
Ceftizoxime—Pruritus—Methotrexate—multiple sclerosis	0.00146	0.00199	CcSEcCtD
Ceftizoxime—Diarrhoea—Methotrexate—multiple sclerosis	0.00142	0.00192	CcSEcCtD
Ceftizoxime—Cephalexin—ALB—multiple sclerosis	0.00134	0.0113	CrCbGaD
Ceftizoxime—Vomiting—Methotrexate—multiple sclerosis	0.00132	0.00179	CcSEcCtD
Ceftizoxime—Rash—Methotrexate—multiple sclerosis	0.0013	0.00177	CcSEcCtD
Ceftizoxime—Dermatitis—Methotrexate—multiple sclerosis	0.0013	0.00177	CcSEcCtD
Ceftizoxime—Nausea—Methotrexate—multiple sclerosis	0.00123	0.00167	CcSEcCtD
Ceftizoxime—SLC15A1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.00116	0.00795	CbGpPWpGaD
Ceftizoxime—SLC15A1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	0.00102	0.00703	CbGpPWpGaD
Ceftizoxime—SLC15A1—SLC-mediated transmembrane transport—ALB—multiple sclerosis	0.000726	0.00498	CbGpPWpGaD
Ceftizoxime—SLC15A1—Transmembrane transport of small molecules—ALB—multiple sclerosis	0.000369	0.00253	CbGpPWpGaD
